GlobeNewswire Inc.··NaNasus Pharma Closes $15M Capital Raise to Fund Epinephrine Product Development
Nasus Pharma raises $15M to advance intranasal epinephrine product toward FDA trials. Funds support NS002 development and pipeline expansion.
NSRXprivate placementcapital raise